OR WAIT null SECS
July 27, 2021
Merck announced that FDA approved Vaxneuvance for active immunization for the prevention of invasive pneumococcal disease.
Nexus Pharmaceuticals celebrated a new manufacturing facility in Pleasant Prairie, Wis.
Amneal Pharmaceuticals received ANDA approval from FDA for the generic version of TobraDex.
Meissa Vaccines’s MV-014-212, an intranasal recombinant live attenuated COVID-19 vaccine, induced mucosal and systemic antibodies against SARS-CoV-2 and two variants of concern.
PerkinElmer has entered into an agreement to acquire BioLegend, a global developer and manufacturer, in a deal valued at $5.25 billion.
July 23, 2021
The EMA’s CHMP has adopted a positive opinion recommending marketing authorization for Moderna’s COVID-19 vaccine (Spikevax) to include adolescents 12 years of age and older.
July 22, 2021
Kadmon Pharmaceuticals selects Onco360 to be a specialty pharmacy partner for Rezurock (belumosudil).
The companies collaborate to develop and commercialize ARV-471, an investigational oral PROTAC (proteolysis targeting chimeras) estrogen receptor protein degrader.
J&J to contribute up to $5 billion to the settlement agreement to resolve opioid-related claims and litigation in the United States.
Aenova has announced plans to open a new new can and bottle filling production line in Cornu, Romania.